Cargando…
Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study
Statins are commonly used for reducing cardiovascular disease risk but therapeutic benefit and reductions in levels of low-density lipoprotein cholesterol (LDL-C) vary among individuals. Other effects, including reductions in C-reactive protein (CRP), also contribute to treatment response. Metabolom...
Autores principales: | Kaddurah-Daouk, Rima, Baillie, Rebecca A., Zhu, Hongjie, Zeng, Zhao-Bang, Wiest, Michelle M., Nguyen, Uyen Thao, Watkins, Steven M., Krauss, Ronald M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2862962/ https://www.ncbi.nlm.nih.gov/pubmed/20445760 http://dx.doi.org/10.1007/s11306-010-0207-x |
Ejemplares similares
-
Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment
por: Kaddurah-Daouk, Rima, et al.
Publicado: (2011) -
Correction: Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment
por: Kaddurah-Daouk, Rima, et al.
Publicado: (2013) -
Metabolomics Reveals Amino Acids Contribute to Variation in Response to Simvastatin Treatment
por: Trupp, Miles, et al.
Publicado: (2012) -
Lipidomics Reveals Early Metabolic Changes in Subjects with Schizophrenia: Effects of Atypical Antipsychotics
por: McEvoy, Joseph, et al.
Publicado: (2013) -
CYP3A4*22 and CYP3A5*3 are associated with increased levels of plasma simvastatin concentrations in the cholesterol and pharmacogenetics study cohort
por: Kitzmiller, Joseph P., et al.
Publicado: (2014)